Literature DB >> 31952781

Metabolic Fitness and Plasticity in Cancer Progression.

Shawn McGuirk1, Yannick Audet-Delage2, Julie St-Pierre3.   

Abstract

Cancer cells have enhanced metabolic needs due to their rapid proliferation. Moreover, throughout their progression from tumor precursors to metastases, cancer cells face challenging physiological conditions, including hypoxia, low nutrient availability, and exposure to therapeutic drugs. The ability of cancer cells to tailor their metabolic activities to support their energy demand and biosynthetic needs throughout disease progression is key for their survival. Here, we review the metabolic adaptations of cancer cells, from primary tumors to therapy resistant cancers, and the mechanisms underpinning their metabolic plasticity. We also discuss the metabolic coupling that can develop between tumors and the tumor microenvironment. Finally, we consider potential metabolic interventions that could be used in combination with standard therapeutic approaches to improve clinical outcome.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; metabolic interventions; metabolism; metastasis; therapy resistance; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 31952781     DOI: 10.1016/j.trecan.2019.11.009

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  26 in total

Review 1.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

2.  Tumor metabolism: metabolic alterations and heterogeneity in cancer progression.

Authors:  Anna Sebestyén
Journal:  Cancer Metastasis Rev       Date:  2021-12       Impact factor: 9.264

3.  Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria.

Authors:  Luciana S Salaverry; Tomás Lombardo; María C Cabral-Lorenzo; Martin L Gil-Folgar; Estela B Rey-Roldán; Laura I Kornblihtt; Guillermo A Blanco
Journal:  Discov Oncol       Date:  2022-07-08

Review 4.  Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take.

Authors:  Patricia Altea-Manzano; Alejandro M Cuadros; Lindsay A Broadfield; Sarah-Maria Fendt
Journal:  EMBO Rep       Date:  2020-09-23       Impact factor: 8.807

Review 5.  The functional roles of TCA cycle metabolites in cancer.

Authors:  Joseph Eniafe; Shuai Jiang
Journal:  Oncogene       Date:  2021-04-16       Impact factor: 9.867

Review 6.  Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential.

Authors:  Li Na Zhao; Mikael Björklund; Matias J Caldez; Jie Zheng; Philipp Kaldis
Journal:  Oncogene       Date:  2021-03-04       Impact factor: 8.756

7.  Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells.

Authors:  Mara Bonelli; Rita Terenziani; Silvia Zoppi; Claudia Fumarola; Silvia La Monica; Daniele Cretella; Roberta Alfieri; Andrea Cavazzoni; Graziana Digiacomo; Maricla Galetti; Pier Giorgio Petronini
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

8.  Inhibition of InsP3R with Xestospongin B Reduces Mitochondrial Respiration and Induces Selective Cell Death in T Cell Acute Lymphoblastic Leukemia Cells.

Authors:  Pablo Cruz; Ulises Ahumada-Castro; Galdo Bustos; Jordi Molgó; Daniela Sauma; Alenka Lovy; César Cárdenas
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

9.  A Novel Long Non-Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis.

Authors:  Yilu Qin; Yixuan Hou; Shuiqing Liu; Pengpeng Zhu; Xueying Wan; Maojia Zhao; Meixi Peng; Huan Zeng; Qiao Li; Ting Jin; Xiaojiang Cui; Manran Liu
Journal:  Adv Sci (Weinh)       Date:  2020-11-30       Impact factor: 17.521

Review 10.  Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation.

Authors:  Tiansheng Li; Chao Mao; Xiang Wang; Ying Shi; Yongguang Tao
Journal:  J Exp Clin Cancer Res       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.